Sanguinarine exhibits potent efficacy against cervical cancer cells through inhibiting the STAT3 pathway in vitro and in vivo

References

• Medina-Alarcón KP, Voltan AR, Fonseca-Santos B, et al. Highlights in nanocarriers for the treatment against cervical cancer. ‎Mater Sci Eng C. 2017;80(undefined):748–759. doi:10.1016/j.msec.2017.07.021
   PubMedGoogle Scholar
• Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–527. doi:10.1001/jamaoncol.2015.073526181261
   PubMed Web of Science ®Google Scholar
• Priyadarsini RV, Murugan RS, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol. 2010;649(1):84–91. doi:10.1016/j.ejphar.2010.09.02020858478
   PubMed Web of Science ®Google Scholar
• Ota T, Takeshima N, Tabata T, Hasumi K, Takizawa K. Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers. British Journal of Cancer. 2007;97(8):1058–1062. doi:10.1094/PDIS-91-4-0467B
   Google Scholar
• Patel V, Mcgurk M. Use of pentoxifylline and tocopherol in radiation-induced fibrosis and fibroatrophy. Br J Oral Maxillofac Surg. 2017;55(3):235–241. doi:10.1016/j.bjoms.2016.11.32328027781
   PubMed Web of Science ®Google Scholar
• Mutrikah N, Winarno H, Amalia T, Djakaria M. Conventional and conformal technique of external beam radiotherapy in locally advanced cervical cancer: dose distribution, tumor response, and side effects. J Phys. 2017;884:012122. doi:10.1088/1742-6596/884/1/012122
   Google Scholar
• Chemaitilly W, Cohen LE. Diagnosis of endocrine disease: endocrine late-effects of childhood cancer and its treatments. Eur J Endocrinol. 2017;176(4):R183–R203. doi:10.1530/EJE-17-005428153840
   PubMed Web of Science ®Google Scholar
• AlQathama A, Prieto JM. Natural products with therapeutic potential in melanoma metastasis. Nat Prod Rep. 2015;32(8):1170–1182. doi:10.1039/c4np00130c26018751
   PubMed Web of Science ®Google Scholar
• Wong-Arce A, Gonzalez-Ortega O, Rosales-Mendoza S. Plant-made vaccines in the fight against cancer. Trends Biotechnol. 2017;35(3):241–256. doi:10.1016/j.tibtech.2016.12.00228153391
   PubMed Web of Science ®Google Scholar
• Shanchao WU, Sheng C, Zhang W, Pharmacy SO. Advance in anti-cancer lead-compounds derived from natural products. J Pharm Pract. 2014;32(5):337–341.
   Google Scholar
• Zhencai L, Ping J, Wang Q, et al. Study on effect mechanism of sanguinarine on proliferation, apoptosis, invasion and migration of cervical cancer cells. Chongqing Med. 2017;46(22):3039–3042.
   Google Scholar
• Wang Q, Dai P, Bao H, et al. Anti-inflammatory and neuroprotective effects of sanguinarine following cerebral ischemia in rats. Exp Ther Med. 2017;13(1):263–268. doi:10.3892/etm.2016.394728123499
   PubMed Web of Science ®Google Scholar
• Cecen E, Altun Z, Ercetin P, Aktas S, Olgun N. Promoting effects of sanguinarine on apoptotic gene expression in human neuroblastoma cells. Asian Pac J Cancer Prev. 2014;15(21):9445–9451. doi:10.7314/apjcp.2014.15.21.944525422239
   PubMedGoogle Scholar
• Yang X-J, Miao F, Yao Y, et al. In vitro antifungal activity of sanguinarine and chelerythrine derivatives against phytopathogenic fungi. Molecules. 2012;17(11):13026–13035. doi:10.3390/molecules17111302623124471
   PubMed Web of Science ®Google Scholar
• Singh CK, Kaur S, George J, et al. Molecular signatures of sanguinarine in human pancreatic cancer cells: A large scale label-free comparative proteomics approach. Oncotarget. 2015;6(12):10335–10348. doi:10.18632/oncotarget.323125929337
   PubMed Web of Science ®Google Scholar
• Park SY, Jin ML, Kim YH, Lee SJ, Park G. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression. Oncol Rep. 2014;31(1):497–504. doi:10.3892/or.2013.284324220687
   PubMed Web of Science ®Google Scholar
• Gong X, Chen Z, Han Q, et al. Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK. BMC Cancer. 2018;18(1):578. doi:10.1186/s12885-018-4242-829783958
   PubMedGoogle Scholar
• Lopez TV, Lappin TRJ, Maxwell P, et al. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells. Int J Cancer. 2011;129(11):2566–2576. doi:10.1002/ijc.2593521442620
   PubMed Web of Science ®Google Scholar
• Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med. 2005;11(12):1314–1321. doi:10.1038/nm132516288283
   PubMed Web of Science ®Google Scholar
• Ma D, Lu B, Feng C, et al. Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS. Cancer Lett. 2016;371(2):194–204. doi:10.1016/j.canlet.2015.11.04426683770
   PubMed Web of Science ®Google Scholar
• Zhang C, Yang L, Wang X-B, et al. Calyxin Y induces hydrogen peroxide-dependent autophagy and apoptosis via JNK activation in human non-small cell lung cancer NCI-H460 cells. Cancer Lett. 2013;340(1):51–62. doi:10.1016/j.canlet.2013.06.02123811287
   PubMed Web of Science ®Google Scholar
• Lu Z, Zhang G, Zhang Y, et al. Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells. Toxicol Appl Pharmacol. 2018;352:46–58. doi:10.1016/j.taap.2018.05.02629800641
   PubMed Web of Science ®Google Scholar
• Li S, Zhuang Z, Wu T, et al. Nicotinamide nucleotide transhydrogenase-mediated redox homeostasis promotes tumor growth and metastasis in gastric cancer. Redox Biol. 2018;18:246–255. doi:10.1016/j.redox.2018.07.01730059901
   PubMed Web of Science ®Google Scholar
• Xiang T, Du L, Pham P, Zhu B, Jiang S. Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway. Cancer Lett. 2015;364(1):79–88. doi:10.1016/j.canlet.2015.04.02725937300
   PubMed Web of Science ®Google Scholar
• Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–248. doi:10.1038/nrclinonc.2018.829405201
   PubMed Web of Science ®Google Scholar
• Liu S, Sun J, Cai B, et al. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer. Tumor Biol. 2016;37(7):1–10.
   PubMedGoogle Scholar
• Wang W, Liu X, Meng Q, Zhang F, Hu K, Gupta S. Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases. PLoS One. 2019;14(4):e0214498. doi:10.1371/journal.pone.021449830986236
   PubMed Web of Science ®Google Scholar
• Ju FJ. Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient. Onco Targets Ther. 2016;9:7555–7561. doi:10.2147/OTT.S11182928008273
   PubMed Web of Science ®Google Scholar
• Ma Y, Yu W, Shrivastava A, et al. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway. Carcinogenesis. 2017;38(10):1047–1056. doi:10.1093/carcin/bgx07028968696
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang G, Zhang PF, et al. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway. J Cell Mol Med. 2017;21(6):1117–1127. doi:10.1111/jcmm.1304327957827
   PubMed Web of Science ®Google Scholar
• Phesse TJ. Abstract 4014: the gp130/Stat3 pathway enables Wnt induced regeneration and tumorigenesis in the mouse intestine. Cancer Res. 2012;72(8 Supplement):4014.
   Google Scholar
• Kim C, Lee S-G, Yang WM, et al. Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model. Cancer Lett. 2018;431:123–141. doi:10.1016/j.canlet.2018.05.03829857127
   PubMed Web of Science ®Google Scholar
• Hatok J, Racay P. Bcl-2 family proteins master regulators of cell survival. Biomol Concepts. 2016;7(4):259–270. doi:10.1515/bmc-2016-001527505095
   PubMedGoogle Scholar
• Steve A, Benjamin B. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin’s lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. Clin Cancer Res. 2003;9(1):316–326.12538484
   PubMed Web of Science ®Google Scholar
• Ren X, Zhao B, Chang H, Xiao M, Wu Y, Liu Y. Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells. Mol Med Rep. 2018;17(6):8289–8299. doi:10.3892/mmr.2018.886829658576
   PubMed Web of Science ®Google Scholar
• Ang LI, Xing YQ, Xiao-Xia LI, et al. Redox regulation of FOXO3a transcription factor. Chin Pharmacol Bull. 2016;32(9):1203–1207.
   Google Scholar
• Akhtar S, Achkar IW, Siveen KS, et al. Sanguinarine induces apoptosis pathway in multiple myeloma cell lines via inhibition of the JaK2/STAT3 signaling. Front Oncol. 2019;9(undefined):285. doi:10.3389/fonc.2019.0028531058086
   PubMedGoogle Scholar
• Lopus M, Panda D. The benzophenanthridine alkaloid sanguinarine perturbs microtubule assembly dynamics through tubulin binding. Febs J. 2010;273(10):2139–2150. doi:10.1111/j.1742-4658.2006.05227.x
   Google Scholar
• Letchmanan K, Shen SC, Ng WK, Tan RB. Dissolution and physicochemical stability enhancement of artemisinin and mefloquine co-formulation via nano-confinement with mesoporous SBA-15. Colloids Surf B. 2017;155(undefined):560–568. doi:10.1016/j.colsurfb.2017.05.003
   PubMedGoogle Scholar
• Büyükköroğlu G, Şenel B, Başaran E, Yenilmez E, Yazan Y. Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer. Eur J Pharm Biopharm. 2016;109(undefined):174–183. doi:10.1016/j.ejpb.2016.10.01727793757
   PubMedGoogle Scholar